Merck | MRK - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Adidas EUR 58M 12M 2026-06
Adyen EUR 4.31M 135K 2026-06
Akzo Nobel EUR 68M 26M 2025-06
Alcon AG USD 53M 1000K 2026-06
Amadeus IT EUR 20.3M 500K 2026-03
Amarin USD 3K 5K 2024-12
AstraZeneca USD 340M 144M 2026-06
BASF EUR 236M 15M 2025-12
Bayer EUR 675M 87M 2025-12
Beiersdorf EUR 7.5M 19.5M 2025-06
Covestro EUR 33M 1000K 2025-09
Danone EUR 252M 6M 2025-12
Fresenius EUR 81M 5M 2025-09
Fresenius Medical Care EUR 83M 4M 2026-06
Genmab DKK 139M 129M 2026-06
Givaudan CHF 58M 7M 2025-12
GlaxoSmithKline GBP 121M 46M 2026-06
GRIFOLS EUR 141.43M 61.28M 2025-06
Hikma Pharmaceutical USD 67M 47M 2025-12
Infineon EUR 78M 5M 2026-06
Lakefront Biotherapeutics EUR 1.72M 940K 2025-09
Linde USD 64M 3M 2025-09
Lonza CHF 84M 14M 2025-06
Merck EUR 137M 33M 2026-06
Novartis USD 462M 119M 2026-06
Philips EUR 83M 26M 2026-03
Roche Holding CHF 304M 7.5M 2025-06
Sanofi EUR 287M 109M 2026-06
UCB EUR 49M 29M 2025-12